September 17, 2009 - The Senate Finance Committee reduced the imaging utilization assumption rate from 90 percent to 65 percent, in essence cutting the originally proposed utilization increase by nearly two-thirds.

September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.

September 16, 2009 - Perceptive Informatics is offering medical imaging measurements for osteoarthritis clinical trials using Optasia's KneeAnalyzer software to supplement its existing medical imaging technology.

September 16, 2009 - BRIT Systems announced today the release of BRIT Vision Version 3.6, a multimodality workstation with a full-feature mammography module.

September 16, 2009 - Cancer patients in Australia have gained access to advanced RapidArc radiotherapy treatments from Varian Medical Systems with its introduction by the leading radiation oncology provider in Queensland.

September 15, 2009 - Citrus Orthopaedics and Joint Institute in Lecanto, Fla., has selected Viztek Opal-ORTHO PACS and U-ARM digital radiography (DR) solutions to implement a conversion to full digital workflow.

September 15, 2009 - SonoSite Inc. introduced the NANOMAXX Ultrasound system at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.

September 15, 2009 - The Finance Committee in a health-overhaul bill calls for device makers to pay $40 billion in fees over 10 years, with the specific amount based on each company's market share.

September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.

September 15, 2009 – Elekta reported net sales increased by 15 percent, profit after taxes increased to SEK 56 million, and earnings per share after dilution were up to SEK 0.62 in the first three months of 2009/2010.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now